US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

250.41

+0.01000.00%

Pre-market: 256.986.57+2.62%06:09 EDT

Volume:217.35K

Turnover:55.00M

Market Cap:494.43M

PE:- -

High:259.83

Open:253.12

Low:242.96

Close:250.40

52wk High:341.93

52wk Low:77.07

Shares:1.97M

Float Shares:1.97M

Volume Ratio:0.83

T/O Rate:11.01%

Dividend:1.00

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

IHH Healthcare Expected to Take Minimal Hit from Tokyo Court Ruling

New F&P Healthcare Bull Expects Growth, Reliable Delivery

National Healthcare Properties Completes Major Facility Portfolio Sale

Health Care Down, but not by Much, on Defensive Bias - Health Care Roundup

Health Care Roundup: Market Talk

Shoulder Innovations Receives 510(k) FDA Clearance for Titanium Implant

MT Newswires Live

Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation

XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™

Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)

Helus Pharma CEO to Spotlight Novel Mental Health Pipeline at Morgan Stanley Healthcare Conference

Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings

Sector Update: Healthcare

MT Newswires Live

Biohaven clinical hold adds level of uncertainty, says H.C. Wainwright

Health Care Roundup: Market Talk

Impact of Biohaven’s partial FDA hold ‘manageable,’ says Raymond James

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)

Community Healthcare management to meet with Piper Sandler

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocugen (OCGN)

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Prelude Therapeutics receives FDA clearance for PRT13722 IND application

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/LABU/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":250.41,"timestamp":1789588800000,"preClose":250.4,"halted":0,"volume":217354,"hourTrading":{"tag":"盘前","latestPrice":256.98,"preClose":250.41,"latestTime":"06:09 EDT","volume":255,"amount":65183.27085,"timestamp":1789639774454,"change":6.57,"changeRate":0.026237,"amplitude":0.013138},"delay":0,"changeRate":0.000039936102236385406,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Pre-Mkt","change":0.01,"latestTime":"09-17 06:35:35 EDT","open":253.12,"high":259.83,"low":242.96,"amount":54997599.92252,"amplitude":0.067372,"askPrice":260.4,"askSize":200,"bidPrice":253.2,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":250.41,"sharesOutstanding":3074486,"nav":250.283,"aum":494179857.69,"dividendRate":0.004,"bidAskSpread":0.002806,"preHourTrading":{"tag":"盘前","latestPrice":256.98,"preClose":250.41,"latestTime":"06:09 EDT","volume":255,"amount":65183.27085,"timestamp":1789639774454,"change":6.57,"changeRate":0.026237,"amplitude":0.013138},"postHourTrading":{"tag":"盘后","latestPrice":252.4,"preClose":250.41,"latestTime":"19:58 EDT","volume":3855,"amount":968174.9559,"timestamp":1789603104098,"change":1.99,"changeRate":0.007947,"amplitude":0.007947},"volumeRatio":0.831749078052628,"impliedVol":0.9487,"impliedVolPercentile":0.68},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.831749078052628,"shares":1974486,"dividePrice":1.0016,"high":259.83,"amplitude":0.067372,"preClose":250.4,"low":242.96,"week52Low":77.07,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":250.41,"eps":0,"divideRate":0.004,"volume":217354,"delay":0,"ttmEps":0,"open":253.12,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":279.02,"twentyDayClose":289.98,"sixtyDayClose":230.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666512498","title":"IHH Healthcare Expected to Take Minimal Hit from Tokyo Court Ruling","url":"https://stock-news.laohu8.com/highlight/detail?id=2666512498","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666512498?lang=en_us&edition=fundamental","pubTime":"2026-09-11 09:20","pubTimestamp":1789089600,"startTime":"0","endTime":"0","summary":"0120 GMT - IHH Healthcare is likely to face minimal operational and financial impact from an unfavorable Tokyo court ruling for its unit Northern TK Venture, says Citi analyst Megat Fais in a note. The unit was ordered to bear litigation costs after the court dismissed its claims against Daiichi Sankyo. NTK filed the lawsuit in October 2023 alleging that it suffered damages, including suspension of a tender offer due to the interference of Daiichi Sankyo. Legal expenses, even of several million ringgit, would be small relative to IHH's more than 2 billion ringgit profit base, Fais says. Investors may remain focused on IHH's volume growth, margins, capacity expansion and earnings prospects across core markets, he adds. Citi has a buy rating and target price of 10.40 ringgit on IHH. Shares are unchanged at 7.89 ringgit.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","XBI","XLV","LU0029874061.USD","DSNKY","Q0F.SI","BK4588","LABU","BK4007","BK6092","BK4137","HCSG","BK4585","BK6511","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666511533","title":"New F&P Healthcare Bull Expects Growth, Reliable Delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2666511533","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666511533?lang=en_us&edition=fundamental","pubTime":"2026-09-11 07:30","pubTimestamp":1789083000,"startTime":"0","endTime":"0","summary":"2330 GMT - Fisher & Paykel Healthcare gains a bull in Citi, which thinks it offers investors both growth and reliable delivery. Citi expects \"sustainable double-digit earnings growth in the midterm and lower exposure to consumer dynamics\" from the medical-device maker than other healthcare stocks across Australia and New Zealand. It upgrades the stock to \"buy\" from \"neutral.\" It raises its price target to NZ$51.00/share from NZ$40.00/share previously. The stock is down 1.3%, at NZ$43.37.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","XBI","BK4581","BK4137","HCSG","LU0029874061.USD","BK4585","BK4588","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666427516","title":"National Healthcare Properties Completes Major Facility Portfolio Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2666427516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666427516?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:05","pubTimestamp":1789074317,"startTime":"0","endTime":"0","summary":"National Healthcare Properties ( ($HLTC) ) just unveiled an update. On September 10, 2026, National Healthcare Properties completed the first tranc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/national-healthcare-properties-completes-major-facility-portfolio-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/national-healthcare-properties-completes-major-facility-portfolio-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","NHP","XBI","BK4225","BK4581","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666516920","title":"Health Care Down, but not by Much, on Defensive Bias - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2666516920","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666516920?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:05","pubTimestamp":1789074300,"startTime":"0","endTime":"0","summary":"Health-care companies fell, but not by as much as the broad market, as traders rotated into defensive sectors.Medical-device maker Boston Scientific has restored its manufacturing, order fulfillment and shipping operations after a disruption by last month's cyberattack.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","XBI","BK4581","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666163445","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666163445","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666163445?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:50","pubTimestamp":1789073400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0208 ET - CSPC Pharmaceutical's coming clinical data presentatio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4588","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666551525","title":"Shoulder Innovations Receives 510(k) FDA Clearance for Titanium Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2666551525","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666551525?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:34","pubTimestamp":1789072441,"startTime":"0","endTime":"0","summary":"Shoulder Innovations  has received the US Food and Drug Administration's 510 clearance for the N-22 Humeral Head titanium implant for patients with metal hypersensitivity, the company said late Thursday.The company said it also initiated the product's full commercial launch.The implant is designed for anatomic total shoulder arthroplasty procedures and complements the company's N-22 Glenosphere implant used in reverse total shoulder arthroplasty procedures, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","BK4211","SI","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666852516","title":"Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666852516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666852516?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:33","pubTimestamp":1789072437,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals ( ($QNRX) ) has issued an update. On September 8, 2026, Quoin Pharmaceuticals reported that the U.S. Food and Drug Administra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-gains-fda-rare-pediatric-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-gains-fda-rare-pediatric-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","QNRX","LABU","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666272515","title":"XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™","url":"https://stock-news.laohu8.com/highlight/detail?id=2666272515","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666272515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070700,"startTime":"0","endTime":"0","summary":"● Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval ● CALGARY, Alberta, Sept.  10, 2026 (GLOBE NE","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359975/0/en/xortx-announces-initiation-of-clinical-and-commercial-manufacturing-of-xorlo.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","XRTX","EES","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666895518","title":"Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666895518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666895518?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:40","pubTimestamp":1789065605,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Eocene (EOCN) and Dyne Therapeutics (DYN). Eocene (EOCN) Maxim Gr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eocene-eocn-and-dyne-therapeutics-dyn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eocene-eocn-and-dyne-therapeutics-dyn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4505","LU0128526141.USD","BK4585","HCSG","DYN","BK4588","BK4137","BK4139","XBI","LU0029874061.USD","LABU","EOCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666518845","title":"Helus Pharma CEO to Spotlight Novel Mental Health Pipeline at Morgan Stanley Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666518845","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666518845?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:27","pubTimestamp":1789064836,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Helus Pharma ( ($HELP) ). Helus Pharma, operating under the Cybin Inc. banner, is a clinical-stage mental healt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/helus-pharma-ceo-to-spotlight-novel-mental-health-pipeline-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/helus-pharma-ceo-to-spotlight-novel-mental-health-pipeline-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","BK4137","BK4581","BK4585","LU0128526141.USD","LABU","XLV","HCSG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559053","title":"Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559053?lang=en_us&edition=fundamental","pubTime":"2026-09-11 01:51","pubTimestamp":1789062660,"startTime":"0","endTime":"0","summary":"Ninety percent of the expensive, widely used biologic drugs facing patent expiration by 2034 have no lower-cost alternatives in development, according to a new report by the Association for Accessible","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","IHE","BK4137","LU0128526141.USD","XLV","BK4585","LABU","HCSG","LU0029874061.USD","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666979055","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2666979055","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666979055?lang=en_us&edition=fundamental","pubTime":"2026-09-11 01:10","pubTimestamp":1789060238,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index shedding 0.2% and the State Street Health Care Select Sector SPDR ETF  down 0.4%.The iShares Biotechnology ETF  dropped 1.3%.In corporate news, Cooper  shares fell past 14% after the company cut its fiscal 2026 guidance. Separately, BofA Securities downgraded Cooper to neutral from buy and lowered its price target to $65 from $80. BofA said Cooper could not sell CooperSurgical at an attractive valuation given competition from the Paragard intrauterine device and the fertility litigation settlement.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1992135399.USD","BK4198","LU2272731782.SGD","XLV","LU2211815571.USD","LU2272731600.USD","COO.AU","BK4585","XBI","BK4581","HCSG","BK4137","LU0029874061.USD","LABU","LU1992135472.HKD","IBB","COO","GB00BDT5M118.USD","BK4588","BK7016","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938597","title":"Biohaven clinical hold adds level of uncertainty, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938597","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666938597?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:45","pubTimestamp":1789058724,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Douglas Tsao keeps a Neutral rating on Biohaven (BHVN) with a $10 price target after the FDA issued a partial clinical hold...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biohaven-clinical-hold-adds-level-of-uncertainty-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biohaven-clinical-hold-adds-level-of-uncertainty-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","SYNB","BK4139","LU1093756325.SGD","LU1093756168.USD","IBB","BHVN","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666927165","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666927165","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666927165?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:20","pubTimestamp":1789057200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0208 ET - CSPC Pharmaceutical's coming clinical data presentatio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4581","BK4585","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666756594","title":"Impact of Biohaven’s partial FDA hold ‘manageable,’ says Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2666756594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666756594?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:15","pubTimestamp":1789053317,"startTime":"0","endTime":"0","summary":"Biohaven’s (BHVN) partial FDA hold on new enrollment for BHV-7000 has driven a 15% selloff, but the setback appears manageable given SK Bio’s prior...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/impact-of-biohavens-partial-fda-hold-manageable-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/impact-of-biohavens-partial-fda-hold-manageable-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BGHQF748.EUR","LU0971096721.USD","LU1804176565.USD","LU1093756168.USD","RJF","BK4139","IE00B64PRP62.GBP","LABU","LU2265009873.SGD","BK4588","IE00B3QW5Z07.USD","BK4585","LU1093756325.SGD","BHVN","LU1363072403.SGD","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666910045","title":"Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666910045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666910045?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:40","pubTimestamp":1789051210,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fortrea Holdings Inc. (FTRE) and Immunome (IMNM). ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fortrea-holdings-inc-ftre-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fortrea-holdings-inc-ftre-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4121","XBI","XLV","LABU","BK4581","BK4137","BK4585","IMNM","HCSG","FTRE","BK4588","LU0029874061.USD","BK4139","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666599760","title":"Community Healthcare management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2666599760","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666599760?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:55","pubTimestamp":1789048524,"startTime":"0","endTime":"0","summary":"Meeting to be held on September 17 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/community-healthcare-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/community-healthcare-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4585","KBWY","XBI","BK4588","BK4225","CHCT","LABU","BK4203"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666996625","title":"Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocugen (OCGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666996625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666996625?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:30","pubTimestamp":1789047034,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4137","ZYME","LABU","XLV","LU0029874061.USD","BK4007","BK4568","LU0128526141.USD","AXSM","BK4588","BK4563","BK4505","PTH","LU2324357040.USD","OCGN","XBI","BK4139","HCSG","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666959862","title":"Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York","url":"https://stock-news.laohu8.com/highlight/detail?id=2666959862","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666959862?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:30","pubTimestamp":1789039800,"startTime":"0","endTime":"0","summary":"CEO Michael Halstead to participate in a fireside chat on Wednesday, September 16, 2026 at 8:30 a.m. EDT.NEW YORK and TORONTO, Sept.  10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA:","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359394/0/en/helus-pharma-to-participate-at-the-morgan-stanley-24th-annual-global-healthcare-conference-in-new-york.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0557290698.USD","LU2023251221.USD","LU2028103732.USD","LU0098860793.USD","HCSG","LU2133065610.SGD","LU1064131342.USD","BK4504","LU0912757837.SGD","LU0528227936.USD","LU0267386448.USD","LU0128526141.USD","LU1988902786.USD","LU0390134368.USD","LU2347655156.SGD","BK4127","LABU","LU0882574139.USD","LU1720051017.SGD","LU1244550494.USD","LU0314104364.USD","LU1548497426.USD","LU0006306889.USD","LU1720051108.HKD","LU0225283273.USD","XLV","LU0106261372.USD","XBI","LU0320765646.SGD","LU1668664300.SGD","BK4588","LU0971096721.USD","LU2271345857.HKD","LU0158827781.USD","LU1732800096.USD","LU1162221912.USD","LU2357305700.SGD","KBWB","IAI","LU1791710400.SGD","LU0158827948.USD","LU0795875169.SGD","LU1989772840.SGD","LU1989772923.USD","LU2111349929.HKD","BK4534","LU0053666078.USD","LU1363072403.SGD","BK4137","LU2089283258.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666856021","title":"Prelude Therapeutics receives FDA clearance for PRT13722 IND application","url":"https://stock-news.laohu8.com/highlight/detail?id=2666856021","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666856021?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:10","pubTimestamp":1789038614,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics (PRLD) announced that the FDA cleared the company to proceed with a Phase 1 study under its Investigational New Drug Applicati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prelude-therapeutics-receives-fda-clearance-for-prt13722-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prelude-therapeutics-receives-fda-clearance-for-prt13722-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4139","BK4585","LABU","PRLD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":10,"totalSize":405,"code":"91000000","status":"200"}]}}